Monday, March 07, 2016 12:23:23 AM
Since the premise is to look backwards to determine whether to invest or not, I showed them this one.
http://www.google.ca/finance?chdnp=1&chdd=1&chds=1&chdv=1&chvs=maximized&chdeh=0&chfdeh=0&chdet=861393600000&chddm=1013202&chls=IntervalBasedLine&cmpto=INDEXDJX:.DJI;INDEXNASDAQ:.IXIC&cmptdms=0;0&q=NASDAQ:AAPL&ntsp=0&ei=wQjdVoDeNMG62Abd_6iQAw
See how easy it is to pick a stock and a time frame and get the result you require? Look, Apple down 76 percent, Stock market up 200 percent! Don't invest in Apple in 1997 because look what history tells you!
If one was so sure of this methodology, I would suggest taking a paltry 250K and shorting NNVC. Since the claims being made, you know, because of the past, that none of the results will be positive from the three new lab agreements or they won't even ship them any cides. If nothing is accomplished 1 year from now, the stock will be worth a maximum of 25 cents.
Don't worry, if the stock goes up past 4 dollars in the next several weeks because whatever reason that happens it will be BS anyway, right? Just short another 250K when it does. When it goes to 9 hey, do it again!
In the first 250K, should the stock do nothing from now until next year and then hit 0.25 you will make 2.25 Million! If it goes to 4 and you short another 250K you will make another 3.75 Million. If it goes to 9 and you short another 250K you will make another 8.75 Million!
Easy money, right?
With that chart you got there it's in the bag! I would recommend covering at 25 cents before bankruptcy because they will still have 20 million in the bank next year at this time and bankruptcy could take a while!
Please short it and I will be right here in March 2017 to congratulate you!
I would recommend that some of the other posters do the same!
Recent NNVC News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/27/2024 08:15:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:30:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 08:05:25 PM
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM